| Sacituzumab |
沙西妥珠单抗 |
1796566-95-4 |
| Nampt-IN-1 |
2-羟基-2-甲基-N-[1,2,3,4-四氢-2-[2-(3-吡啶基氧基)乙酰基]-6-异喹啉基]-1-丙烷磺酰胺 |
1698878-14-6 |
| 5-SULFOSALICYLALDEHYDE, SODIUM SALT |
苯磺酸,3-醛基-4-羟基-, 钠盐 |
16856-04-5 |
| Sulesomab |
硫索单抗 |
167747-19-5 |
| Vonlerolizumab |
Vonlerolizumab |
1638935-72-4 |
| LML-134 |
LML-134 |
1542135-76-1 |
| Ticagrelor diastereoMer |
替格瑞洛非对映体 |
1459719-81-3 |
| Mirvetuximab |
Mirvetuximab |
1453084-36-0 |
| Crotedumab |
Crotedumab |
1452387-69-7 |
| Firivumab |
Firivumab |
1443004-15-6 |
| 4-(6-methacryloyloxyhexyloxy)phenol |
4-(6-甲基丙烯酰氧基己氧基)苯酚 |
142627-92-7 |
| AMTHAMINE DIHYDROBROMIDE |
CS-336 |
142457-00-9 |
| SC-43 |
SC-43 |
1400989-25-4 |
| MPMKMQHJHDHPBE-RUZDIDTESA-N |
MPMKMQHJHDHPBE-RUZDIDTESA-N |
1391076-61-1 |
| Tuvirumab |
Tuvirumab |
138660-97-6 |
| Ulocuplumab |
Ulocuplumab |
1375830-34-4 |
| (E)-17-ethyl-1,14-dihydroxy-12[(E)-2-(4-hydroxy-3-Methoxycyclohexyl)-1-Methylvinyl]-23,25-diMethoxy-13,19,21,27-tetraMethyl-11,28-dioxa-4-azatricyclo[22.3.1.0(super4,9)]octacos-18-ene-2,3,10,16-tetrone |
他克莫司相关物质A |
135635-46-0 |
| Pritoxaximab |
Pritoxaximab |
1351470-16-0 |
| CYM50308 |
CYM50308 |
1345858-76-5 |
| 1-Piperidinecarboxamide, 4-(1,2-dihydro-2-oxo-3-quinolinyl)-N-[(1R)-1-[(7-methyl-1H-indazol-5-yl)methyl]-2-[4-(1-methyl-4-piperidinyl)-1-piperazinyl]-2-oxoethyl]- |
1-Piperidinecarboxamide, 4-(1,2-dihydro-2-oxo-3-quinolinyl)-N-[(1R)-1-[(7-methyl-1H-indazol-5-yl)methyl]-2-[4-(1-methyl-4-piperidinyl)-1-piperazinyl]-2-oxoethyl]- |
1337918-83-8 |
QQ
微信
